400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cytoskeleton / FAK / PF-562271 besylate/PF 562271 苯磺酸盐
CAS No.: 939791-38-5
Synonyms: VS-6062 besylate
PF-562271 besylate is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and > 100-fold selectivity against other protein kinases, except for some CDKs.
生物活性
实验方案
技术信息
CAS号 | 939791-38-5 | 储存条件 |
|
|||||||||
分子式 | C27H26F3N7O6S2 | 运输 | 蓝冰 | |||||||||
分子量 | 665.66 | 别名 | VS-6062 besylate | |||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
ALL-PO cell | - | Growth inhibition assay | - | Inhibition of human ALL-PO cell growth in a cell viability assay, IC50=1.01584 μM | SANGER |
human 8305C cell | - | Growth inhibition assay | - | Inhibition of human 8305C cell growth in a cell viability assay, IC50=1.09904 μM | SANGER |
human AGS cell | - | Growth inhibition assay | - | Inhibition of human AGS cell growth in a cell viability assay, IC50=1.52124 μM | SANGER |
human AN3-CA cell | - | Growth inhibition assay | - | Inhibition of human AN3-CA cell growth in a cell viability assay, IC50=1.21867 μM | SANGER |
human BC-1 cell | - | Growth inhibition assay | - | Inhibition of human BC-1 cell growth in a cell viability assay, IC50=1.61664 μM | SANGER |
human BCPAP cell | - | Growth inhibition assay | - | Inhibition of human BCPAP cell growth in a cell viability assay, IC50=1.01288 μM | SANGER |
human BPH-1 cell | - | Growth inhibition assay | - | Inhibition of human BPH-1 cell growth in a cell viability assay, IC50=1.28766 μM | SANGER |
human CAL-33 cell | - | Growth inhibition assay | - | Inhibition of human CAL-33 cell growth in a cell viability assay, IC50=1.12938 μM | SANGER |
human CAL-62 cell | - | Growth inhibition assay | - | Inhibition of human CAL-62 cell growth in a cell viability assay, IC50=1.31909 μM | SANGER |
human CGTH-W-1 cell | - | Growth inhibition assay | - | Inhibition of human CGTH-W-1 cell growth in a cell viability assay, IC50=1.61679 μM | SANGER |
human COLO-205 cell | - | Growth inhibition assay | - | Inhibition of human COLO-205 cell growth in a cell viability assay, IC50=0.48658 μM | SANGER |
human COLO-829 cell | - | Growth inhibition assay | - | Inhibition of human COLO-829 cell growth in a cell viability assay, IC50=0.76176 μM | SANGER |
human DU-145 cell | - | Growth inhibition assay | - | Inhibition of human DU-145 cell growth in a cell viability assay, IC50=2.49118 μM | SANGER |
human DU-4475 cell | - | Growth inhibition assay | - | Inhibition of human DU-4475 cell growth in a cell viability assay, IC50=2.14759 μM | SANGER |
human EW-13 cell | - | Growth inhibition assay | - | Inhibition of human EW-13 cell growth in a cell viability assay, IC50=1.63466 μM | SANGER |
human HSC-2 cell | - | Growth inhibition assay | - | Inhibition of human HSC-2 cell growth in a cell viability assay, IC50=1.5395 μM | SANGER |
human HUTU-80 cell | - | Growth inhibition assay | - | Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50=1.44886 μM | SANGER |
human IGROV-1 cell | - | Growth inhibition assay | - | Inhibition of human IGROV-1 cell growth in a cell viability assay, IC50=0.81038 μM | SANGER |
human KM12 cell | - | Growth inhibition assay | - | Inhibition of human KM12 cell growth in a cell viability assay, IC50=0.38557 μM | SANGER |
human KYSE-150 cell | - | Growth inhibition assay | - | Inhibition of human KYSE-150 cell growth in a cell viability assay, IC50=1.35236 μM | SANGER |
human KYSE-270 cell | - | Growth inhibition assay | - | Inhibition of human KYSE-270 cell growth in a cell viability assay, IC50=1.04714 μM | SANGER |
human MDA-MB-231 cell | - | Growth inhibition assay | - | Inhibition of human MDA-MB-231 cell growth in a cell viability assay, IC50=2.49572 μM | SANGER |
human MES-SA cell | - | Growth inhibition assay | - | Inhibition of human MES-SA cell growth in a cell viability assay, IC50=1.30682 μM | SANGER |
human MFE-296 cell | - | Growth inhibition assay | - | Inhibition of human MFE-296 cell growth in a cell viability assay, IC50=2.47792 μM | SANGER |
human MG-63 cell | - | Growth inhibition assay | - | Inhibition of human MG-63 cell growth in a cell viability assay, IC50=0.80637 μM | SANGER |
human MZ1-PC cell | - | Growth inhibition assay | - | Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50=1.62312 μM | SANGER |
human NCI-H460 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H460 cell growth in a cell viability assay, IC50=2.04839 μM | SANGER |
human NCI-H650 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H650 cell growth in a cell viability assay, IC50=0.83154 μM | SANGER |
human NKM-1 cell | - | Growth inhibition assay | - | Inhibition of human NKM-1 cell growth in a cell viability assay, IC50=1.27506 μM | SANGER |
human RT-112 cell | - | Growth inhibition assay | - | Inhibition of human RT-112 cell growth in a cell viability assay, IC50=0.9846 μM | SANGER |
human SIG-M5 cell | - | Growth inhibition assay | - | Inhibition of human SIG-M5 cell growth in a cell viability assay, IC50=1.48487 μM | SANGER |
human SK-UT-1 cell | - | Growth inhibition assay | - | Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50=1.44647 μM | SANGER |
human SNU-387 cell | - | Growth inhibition assay | - | Inhibition of human SNU-387 cell growth in a cell viability assay, IC50=2.5282 μM | SANGER |
human ST486 cell | - | Growth inhibition assay | - | Inhibition of human ST486 cell growth in a cell viability assay, IC50=1.53278 μM | SANGER |
human SW1710 cell | - | Growth inhibition assay | - | Inhibition of human SW1710 cell growth in a cell viability assay, IC50=1.62628 μM | SANGER |
human SW982 cell | - | Growth inhibition assay | - | Inhibition of human SW982 cell growth in a cell viability assay, IC50=0.3282 μM | SANGER |
human U251 cell | - | Growth inhibition assay | - | Inhibition of human U251 cell growth in a cell viability assay, IC50=1.74031 μM | SANGER |
MV-4-11 cell | - | Growth inhibition assay | - | Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50=0.2766 μM | SANGER |
NCI-H810 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H810 cell growth in a cell viability assay, IC50=1.10776 μM | SANGER |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网